Cambridge, MA, United States
Cambridge, MA, United States

Time filter

Source Type

CRISPR/CAS-related compositions and methods for treatment of HSV-1 are disclosed.


CRISPR/CAS-related compositions and methods for treatment of Sickle Cell Disease (SCD) are disclosed.


CRISPR/Cas-related composition and methods for treatment of cancer, in particular by using gRNA molecules comprising a targeting domain which is complementary with a target domain from the FAS, BID, CTLA4, PDCD1, CBLB, PTPN6, TRAC or TRBC gene. In some embodiments, gRNAs are used with Cas9 enzymes to cause a cleavage event in said genes within engineered chimeric antigen receptor (CAR) T cells. In some embodiments, CAR T cells are modified to reduce, decrease or repress expression of said genes using gRNAs and Cas9 enzymes; said modified CAR T-cells are meant for therapeutic uses, especially for cancer.


CRISPR/Cas-related compositions and methods for treatment of Usher Syndrome and/or Retinitis Pigmentosa are disclosed herein.


CRISPR/Cas-related composition and methods for treatment of cancer, in particular by using gRNA molecules comprising a targeting domain which is complementary with a target domain from the FAS, BID, CTLA4, PDCD1, CBLB, PTPN6, TRAC or TRBC gene. In some embodiments, gRNAs are used with Cas9 enzymes to cause a cleavage event in said genes within engineered chimeric antigen receptor (CAR) T cells. In some embodiments, CAR T cells are modified to reduce, decrease or repress expression of said genes using gRNAs and Cas9 enzymes; said modified CAR T-cells are meant for therapeutic uses, especially for cancer.


CRISPR/CAS-related compositions and methods for treatment of Lebers Congenital Amaurosis 10 (LCAIO) are disclosed.


CRISPR/CAS-related compositions and methods for treatment of a subject at risk for or having a HIV infection or AIDS are disclosed.


CRISPR/CAS-related compositions and methods for treatment of Cystic Fibrosis (CF).


CRISPR/CAS-related compositions and methods for treatment of HSV-1 are disclosed.


CRISPR/CAS-related compositions and methods for treatment of a subject at risk for or having a HIV infection or AIDS are disclosed.

Loading Editas Medicine collaborators
Loading Editas Medicine collaborators